Revlimid and Imnovid Triple Combination for Multiple Myeloma Treatment Get EU Approval
Celgene Corporation (CELG) got the European Commission approval of two of its triple regiments for multiple myeloma treatment.
The two oral medicines are used in combination with dexamethasone.
https://blog.genexi.ru/news/Revlimid-and-Imnovid-Triple-Combination-for-Multiple-Myeloma-Treatment-Get-EU-Approval-en